City

Bethesda (1)

Durham (1)

Rochester (1)

Condition

Immune Deficiencies (3)

Hematologic Malignancies (1)

Hematological Disease (1)

Inborn Errors of Metabolism Disorders (1)

Lymphoma (1)

Multiple Myeloma (1)

Myelofibrosis (1)

Solid Tumors (1)

Overall Status

Available (1)

Completed (1)

Recruiting (1)

Phase

phase 1 (1)

Sponsor

Joanne Kurtzberg, MD (1)

National Institute of Allergy and Infectious Diseases (NIAID) (1)

University of Rochester (1)

Collaborator

Duke University (1)

Miltenyi Biotec, Inc. (1)

Study Documents

Intervention Type

biological (1)

drug (1)

procedure (1)

radiation (1)

Funder Type

Other (2)

NIH (1)

Study Type

Expanded Access (1)

Interventional (1)

Observational (1)

immune deficiencies

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Infections and Infection Susceptibility

Recruiting

Immune Deficiencies

Bethesda, Maryland

National Institutes of Health Clinical Center

Jan 25, 2023

Hematologic Malignancies, Inborn Errors of Metabolism Disorders, Immune Deficiencies Trial in Durham (CliniMACS CD34 Reagent

Available

Hematologic Malignancies
+2 more

CliniMACS CD34 Reagent System

Durham, North Carolina

Duke University Medical Center

Nov 12, 2021

Hematological Disease, Immune Deficiencies, Solid Tumors Trial in Rochester (radiation, drug, procedure)

Completed

Hematological Disease
+5 more

Total Body Irradiation 1200 cGy
+9 more

Rochester, New York

Wilmot Cancer Institute

Nov 1, 2021